Abstract

Use of Domperidone as a Prokinetic and Antiemetic

Author(s): Albright Lisa M

Issue: Mar/Apr 2005 - Health and Wellness

Page(s): 120-125

Download in electronic PDF format for $75
  • Use of Domperidone as a Prokinetic and Antiemetic Page 1
  • Use of Domperidone as a Prokinetic and Antiemetic Page 2
  • Use of Domperidone as a Prokinetic and Antiemetic Page 3
  • Use of Domperidone as a Prokinetic and Antiemetic Page 4
  • Use of Domperidone as a Prokinetic and Antiemetic Page 5
  • Use of Domperidone as a Prokinetic and Antiemetic Page 6

Abstract

Domperidone is a synthetic benzimidazole compound that acts as a dopamine D2 receptor antagonist. Its localization outside the blood-brain barrier and antiemetic properties have made it a useful adjunct in therapy for Parkinson’s disease. There has been renewed interest in antidopaminergic prokinetic agents since the withdrawal of cisapride, a 5-HT4 agonist, from the market. Domperidone also is as a prokinetic agent for treatment of upper gastrointestinal motility disorders. It continues to be an attractive alternative to metoclopramide because it has fewer neurological side effects. Patients receiving domperidone or other prokinetic agents for diabetic gastropathy or gastroparesis should also be managing diet, lifestyle, and other medications to optimize gastric motility.

Related Keywords

  • domperidone
  • gastrointestinal motility
  • dopamine D2 receptor
  • vomiting
  • Parkinson's disease
  • prokinetic
  • antiemetic
  • diabetic gastropathy
  • gastroparesis
  • diabetes
  • gastric emptying

Related Categories

  • DIABETES
  • GASTROENTEROLOGY
  • FREE SAMPLES

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Mar/Apr 2005
Pg. 120-125
View Sample
Use of Domperidone as a Prokinetic and Antiemetic
Author(s): Albright Lisa M
May/Jun 2003
Pg. 170-174
Five Compounds for Treating Diabetes-Related Conditions
Author(s): Meece Jerry
Nov/Dec 2021
Pg. 500
Domperidone 5 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
May/Jun 2014
Pg. 203-207
Literature Review: The Dual Role of Domperidone in Gastroparesis and Lactation
Author(s): Phan Ha, DeReese Annie, Day A J, Carvalho Maria
Jul/Aug 2019
Pg. 316
Domperidone 5 mg/mL in Oral Mix
Author(s): Allen Loyd V Jr
Jul/Aug 2012
Pg. 276-286
Compounding Prokinetic Medications for Companion Animals
Author(s): Gaskins Jessica
Mar/Apr 2000
Pg. 88-90
Complications of Diabetes
Author(s): Key David M
Jan/Feb 2003
Pg. 21-23
Profile of a Practice: Ward Drug Company Diabetic Shoppe and Prescription Compounding Center
Author(s): Vail Jane
Jan/Feb 2006
Pg. 61
Domperidone 1-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Jul/Aug 2000
Pg. 250-251
Nausea and Vomiting in Hospice Patients
Author(s): Boomsma Diane
Jul/Aug 2003
Pg. 288-291
Basics of Compounding for Raynaud's Disease
Author(s): Glasnapp Andrew
Jul/Aug 2000
Pg. 276-279
Nicotinamide-Adenine Dinucleotide (NADH) in Parkinson's Disease and Alzheimer's Disease
Author(s): Glasnapp Andrew, Schaefer Erin
Jul/Aug 2004
Pg. 265-267
Case Report: Wound Care of a Diabetic Foot Ulcer
Author(s): Wynn Tom
May/Jun 2003
Pg. 188-191
Treating Canine Hepatic Disease
Author(s): Davidson Gigi S
Sep/Oct 2004
Pg. 329-335
Domperidone in Lactation: Use as a Galactagogue
Author(s): Albright Lisa M
May/Jun 2012
Pg. 243
Metoclopramide 5-mg/mL Injection
Author(s): Allen Loyd V Jr
Mar/Apr 2000
Pg. 84-87
The Clinical Pharmacist's Role in Compounding for the Diabetic Patient
Author(s): Harshbarger Robert, Harshbarger Diana
Mar/Apr 2000
Pg. 103-104
Diabetes Book Reviews
Author(s): Reed-Kane Dana
Jan/Feb 1997
Pg. 28
Antiemetic Suppositories of the Gralla Type
Author(s): Allen Loyd V Jr
Sep/Oct 1997
Pg. 328
Metoclopramide-Lorazepam-Mannitol-Prochlorperazine Antiemetic Injection
Author(s): Allen Loyd V Jr